Patent intelligence · US
US 7868162
Antimicrobial and antiviral compounds and methods for their use
Antimicrobial and antiviral compounds and methods for their use
Patent details — US 7868162
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jan 11, 2011
- Expiration
- Jan 6, 2031
- Applicant
- Lakewood Amedex, Inc.
- Claims
- 3
- CPC classes
- A61K, A61K31/7072, A61K31/7076, A61K9/0014
Quick answer
US 7868162 (Antimicrobial and antiviral compounds and methods for their use) is held by Lakewood Amedex, Inc.. Status: granted. Granted Jan 11, 2011. Expires Jan 6, 2031 (4 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Lakewood Amedex, Inc.
- Grant date
- Expiration
- Claims
- 3
- CPC classes
- A61K, A61K31/7072, A61K31/7076, A61K9/0014, A61K9/1271, A61P
More from Lakewood Amedex, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12156883
Bisphosphocin gel formulations and uses thereof
granted -
US 12054509
Antimicrobial compounds, compositions, and uses thereof
granted -
US 12030908
Antimicrobial compounds, compositions, and uses thereof
granted -
US 11795192
Antimicrobial compounds, compositions, and uses thereof
granted -
US 11377468
Antimicrobial compounds, compositions, and uses thereof
granted -
US 11123357
Methods and compositions for treating oral mucositis
granted -
US 11096954
Bisphosphocin gel formulations and uses thereof
granted -
US 10981943
Antimicrobial compounds, compositions, and uses thereof
granted
Frequently asked questions
What is US patent 7868162?
US 7868162 (Antimicrobial and antiviral compounds and methods for their use) is held by Lakewood Amedex, Inc.. Status: granted. Granted Jan 11, 2011. Expires Jan 6, 2031 (4 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 7868162?
Lakewood Amedex, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 18 pharmaceutical patents for this assignee.
When does US 7868162 expire?
Our index shows an expiration date of Jan 6, 2031 (4 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.